Bain Capital Life Sciences Investors, LLC, 10% Owner, Director at Replimune Group, Inc. (REPL), bought 2,838,968 shares at $15.00 ($7.5M) on 2018-07-24, disclosed to the SEC on 2018-07-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,338,968 | $0 | 0.0% |
| 2 | $15.00 | 500,000 | $7.5M | 100.0% |
| Total | $2.64 avg | 2,838,968 | $7.5M | 100% |
| Filing → |
| HTFL | SELL | 2026-02-06 | $56.1M | — | Filing → |
| OLMA | BUY | 2025-01-13 | $1.7M | — | Filing → |
| ANNX | BUY | 2023-05-30 | $639K | — | Filing → |